(a)The controlled substances listed in this
section are included in schedule IV.
(b)Narcotic drugs. Unless specifically excepted in a rule adopted
by the board or unless listed in another schedule, any material,
compound, mixture, or preparation containing any of the following
narcotic drugs, or their salts calculated as the free anhydrous base or
alkaloid, in the following limited quantities:
(1)Not more than 1 milligram of difenoxin (9618) and not less
than 25 micrograms of atropine sulfate per dosage unit.
(2)Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
diphenyl-3-methyl-2-propionoxybutane (9278).
(c)Depressants. Unless specifically excepted in a rule adopted by
the board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any
Free access — add to your briefcase to read the full text and ask questions with AI
(a) The controlled substances listed in this
section are included in schedule IV.
(b) Narcotic drugs. Unless specifically excepted in a rule adopted
by the board or unless listed in another schedule, any material,
compound, mixture, or preparation containing any of the following
narcotic drugs, or their salts calculated as the free anhydrous base or
alkaloid, in the following limited quantities:
(1) Not more than 1 milligram of difenoxin (9618) and not less
than 25 micrograms of atropine sulfate per dosage unit.
(2) Dextropropoxyphene (alpha- (+)-4-dimethylamino-1,2-
diphenyl-3-methyl-2-propionoxybutane (9278).
(c) Depressants. Unless specifically excepted in a rule adopted by
the board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances, including its salts, isomers, and salts of isomers whenever
the existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation:
Alfaxalone (2731).
Alprazolam (2882).
Barbital (2145).
Brexanolone (2400).
Bromazepam (2748).
Camazepam (2749).
Carisoprodol.
Chloral betaine (2460).
Chloral hydrate (2465).
Chlordiazepoxide (2744).
Clobazam (2751).
Clonazepam (2737).
Clorazepate (2768).
Clotiazepam (2752).
Cloxazolam (2753).
Daridorexant (2410).
Delorazepam (2754).
Diazepam (2765).
Dichloralphenazone (2467).
Estazolam (2756).
Ethchlorvynol (2540).
Ethinamate (2545).
Ethyl loflazepate (2758).
Fludiazepam (2759).
Flunitrazepam (2763).
Flurazepam (2767).
Fospropofol (2138).
Halazepam (2762).
Haloxazolam (2771).
Ketazolam (2772).
Lemborexant (2245).
Loprazolam (2773).
Lorazepam (2885).
Lormetazepam (2774).
Mebutamate (2800).
Medazepam (2836).
Meprobamate (2820).
Methohexital (2264).
Methylphenobarbital (mephobarbital) (2250).
Midazolam (2884).
Nimetazepam (2837).
Nitrazepam (2834).
Nordiazepam (2838).
Oxazepam (2835).
Oxazolam (2839).
Paraldehyde (2585).
Petrichloral (2591).
Phenobarbital (2285).
Pinazepam (2883).
Prazepam (2764).
Quazepam (2881).
Remimazolam (2846).
Suvorexant (2223).
Temazepam (2925).
Tetrazepam (2886).
Triazolam (2887).
Zaleplon (2781).
Zolpidem (Ambien) (2783).
Zopiclone (2784).
Zuranolone (2420).
(d) Stimulants. Unless specifically excepted in a rule adopted by the
board or unless listed in another schedule, any material, compound,
mixture, or preparation which contains any quantity of the following
substances having a stimulant effect on the central nervous system,
including its salts, isomers (whether optical, position, or geometric),
and salts of such isomers whenever the existence of such salts, isomers,
and salts of isomers is possible within the specific chemical
designation:
Cathine ((+)-norpseudoephedrine) (1230).
Diethylpropion (1610).
Fencamfamin (1760).
Fenproporex (1575).
Mazindol (1605).
Mefenorex (1580).
Modafinil (1680).
Pemoline (including organometallic complexes and chelates
thereof) (1530).
Phentermine (1640).
Pipradrol (1750).
Serdexmethylphenidate (1729).
Sibutramine (1675).
Solriamfetol (2-amino-3-phenylpropyl carbamate;
benzenepropanol, beta-amino-, carbamate (ester)) (1650).
SPA ((-)-1-dimethylamino-1,2-diphenylethane (1635).
(e) Other substances. Unless specifically excepted or unless listed
in another schedule, any material, compound, mixture, or preparation
which contains any quantity of the following substances including its
salts:
Butorphanol (including its optical isomers) (9720).
Pentazocine (9709).
(f) Tramadol (Ultram).
(g) The board may except by rule any compound, mixture, or
preparation containing any depressant substance listed in subsection
(b), (c), (d), or (e), from the application of any part of this article if the
compound, mixture, or preparation contains one (1) or more active
medicinal ingredients not having a depressant effect on the central
nervous system, and if the admixtures are included therein in
combinations, quantity, proportion, or concentration that vitiate the
potential for abuse of the substances which have a depressant effect on
the central nervous system.
As added by Acts 1976, P.L.148, SEC.7. Amended by Acts
1977, P.L.344, SEC.2; Acts 1979, P.L.303, SEC.6; Acts 1981, P.L.170,
SEC.5; P.L.333-1983, SEC.4; P.L.77-1984, SEC.14; P.L.200-1987,
SEC.12; P.L.288-2001, SEC.17; P.L.8-2004, SEC.3; P.L.22-2008,
SEC.4; P.L.283-2013, SEC.3; P.L.56-2015, SEC.5; P.L.48-2023,
SEC.6; P.L.84-2024, SEC.5.